SNSE Sensei Biotherapeutics Inc
Price (delayed)
$0.366
Market cap
$9.23M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.2
Enterprise value
$3.08M
Sensei Biotherapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and delivery of next generation immunotherapies for the treatment of cancer and infectious diseases. The company has developed
Highlights
SNSE's debt is down by 38% YoY and by 14% from the previous quarter
The net income has increased by 12% year-on-year
SNSE's equity is down by 41% YoY and by 16% from the previous quarter
The quick ratio is down by 35% YoY and by 12% from the previous quarter
Key stats
What are the main financial stats of SNSE
Market
Valuations
Earnings
Shares outstanding
25.21M
Market cap
$9.23M
Enterprise value
$3.08M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.24
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$32.61M
Net income
-$30.16M
EBIT
-$30.07M
EBITDA
-$27.19M
Free cash flow
-$24.82M
Per share
Balance sheet
Liquidity
EPS
-$1.2
EPS diluted
-$1.2
Free cash flow per share
-$0.99
Book value per share
$1.53
Revenue per share
$0
TBVPS
$1.81
Total assets
$45.36M
Total liabilities
$6.98M
Debt
$3.85M
Equity
$38.39M
Working capital
$36.48M
Debt to equity
0.1
Current ratio
7.7
Quick ratio
7.59
Net debt/EBITDA
0.23
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-53.6%
Return on equity
-61.9%
Return on invested capital
-70.2%
Return on capital employed
-75.3%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
SNSE stock price
How has the Sensei Biotherapeutics stock price performed over time
Intraday
6.09%
1 week
-16.06%
1 month
-21.46%
1 year
-63.03%
YTD
-25.32%
QTD
-7.11%
Financial performance
How have Sensei Biotherapeutics's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$32.61M
Net income
-$30.16M
Gross margin
N/A
Net margin
N/A
The net income has increased by 12% year-on-year
The operating income has grown by 12% YoY
Growth
What is Sensei Biotherapeutics's growth rate over time
Valuation
What is Sensei Biotherapeutics stock price valuation
P/E
N/A
P/B
0.24
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The price to book (P/B) is 71% lower than the 5-year quarterly average of 0.8 and 43% lower than the last 4 quarters average of 0.4
SNSE's equity is down by 41% YoY and by 16% from the previous quarter
Efficiency
How efficient is Sensei Biotherapeutics business performance
The ROIC has shrunk by 62% YoY and by 18% QoQ
SNSE's ROE is down by 41% YoY and by 15% from the previous quarter
The company's return on assets fell by 39% YoY and by 14% QoQ
Dividends
What is SNSE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for SNSE.
Financial health
How did Sensei Biotherapeutics financials performed over time
Sensei Biotherapeutics's total assets has decreased by 39% YoY and by 15% from the previous quarter
The quick ratio is down by 35% YoY and by 12% from the previous quarter
SNSE's debt is 90% less than its equity
SNSE's equity is down by 41% YoY and by 16% from the previous quarter
SNSE's debt is down by 38% YoY and by 14% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.